semaglutide
Cut 50% of Heavy Drinking With Obesity Treatment
An 8-week GLP-1 regimen cut heavy-drinking days by 52%, showing medication can halve alcohol excess in patients with obesity. In trials the drug also produced meaningful weight loss, making it a dual-action tool for clinicians. The findings are reshaping how we combine pharmacology with counseling. Medical Disclaimer: This article is